Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142194 · ClinicalTrials.gov registry record
Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 47
- Enrollment target
NCT00142194 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 47 participants.
The verdict
NCT00142194 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent relapses of the abnormal heart beats. One explanation for the high relapse rate is that the treatments might not address the underlying cause of atrial fibrillation. Recently, the investigators have found that atrial fibrillation is associated with increased oxidative stress. This is a condition where abnormal oxygen forms are produced. These forms harm the cells of the heart, causing them to beat abnormally. The investigators have found increased oxidative stress in pig and mouse models of atrial fibrillation. They would like to see if oxidative stress is present in humans with atrial fibrillation. In this study, they will compare blood markers of oxidative stress between patients with and without atrial fibrillation. It is the expectation that participants with atrial fibrillation will have more abnormal blood markers of atrial fibrillation. This study requires participants to visit their doctors, undergo a history and physical examination, and give blood only once.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00142194
The ClinicalTrials.gov registry entry for NCT00142194 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00142194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00142194 about?
NCT00142194 is a clinical study titled "Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation". Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent relapses of the abnormal heart beats. One explanation for the high relapse rate is that the treatments m...
What is the current status of trial NCT00142194?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2005-06. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00142194?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.